Silibinin enhances anti-renal fibrosis effect of MK-521 via downregulation of TGF-β signaling pathway-Reference-Cited by-同舟云学术

Silibinin enhances anti-renal fibrosis effect of MK-521 via downregulation of TGF-β signaling pathway

Published:2020-01-18 Issue:2 Volume:33 Page:330-336
ISSN:1749-0774
Container-title:Human Cell
language:en
Short-container-title:Human Cell

Author:

Ma Zhongchao,Zang Wenwen,Wang Huaiguo,Wei Xiaojing

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Cell Biology

Link

http://link.springer.com/content/pdf/10.1007/s13577-019-00314-9.pdf

Reference30 articles.

1. Hewitson TD. Renal tubulointerstitial fibrosis: common but never simple. Am J Physiol Renal Physiol. 2009;296:F1239–44.

2. Liu Y. Cellular and molecular mechanisms of renal fibrosis. Nat Rev Nephrol. 2011;7:684–96.

3. Santos-Paul MA, Neves RS, Gowdak LHW, et al. Cardiovascular risk reduction with periodontal treatment in patients on the waiting list for renal transplantation. Clin Transplant. 2019;4:e13658.

4. Jha V, Garcia-Garcia G, Iseki K, et al. Chronic kidney disease: global dimension and perspectives. Lancet. 2013;382:260–72.

5. Diwan V, Brown L, Gobe GC. Adenine-induced chronic kidney disease in rats. Nephrology (Carlton). 2018;23:5–11.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between dietary intake of flavonoid and chronic kidney disease in US adults: Evidence from NHANES 2007-2008, 2009-2010, and 2017-2018;PLOS ONE;2024-08-27

2. Silibinin attenuates TGF-β2-induced fibrogenic changes in human trabecular meshwork cells by targeting JAK2/STAT3 and PI3K/AKT signaling pathways;Experimental Eye Research;2024-07

3. Synthesis, characterization, and in vitro–in ovo toxicological screening of silibinin fatty acids conjugates as prodrugs with potential biomedical applications;Biomolecules and Biomedicine;2024-06-21

4. Silibinin Overcomes EMT-Driven Lung Cancer Resistance to New-Generation ALK Inhibitors;Cancers;2022-12-11

5. Identification of selective homeodomain interacting protein kinase 2 inhibitors, a potential treatment for renal fibrosis;Bioorganic Chemistry;2022-09